Navigation Links
The Boston Eye Group Implants First Intraocular Pressure Transducer for Glaucoma Monitoring
Date:1/25/2013

Brookline, MA (PRWEB) January 25, 2013

Glaucoma is characterized by slow, painless loss of vision due to optic nerve damage mostly related to an elevated eye pressure. Until now, doctors have relied on in-office methods to measure the eye pressure.This requires a visit to the doctor’s office every few weeks to few months. A new surgically implanted device may for the first time allow home monitoring of eye pressure.Once inside the eye, it relays measurements to a remote-held reader wirelessly.

Following years of animal research, Samir Melki MD PhD of Harvard Medical School and the Boston Eye Group implanted the device for the first time in a patient with Glaucoma during cataract surgery. “This may be a game-changer when it comes to glaucoma management” said Dr. Melki. “ It should allow us to understand the disease through a tremendous ability to collect pressure data”

The wireless intraocular pressure transducerwas developed by Implandata GmbH (Hannover, Germany). It integrates pressure sensors, temperature sensor, identification encoder, analog-to-digital encoder, and telemetry unit into a single microelectromechanical system-application specific integrated circuit (MEMS-ASIC). This digital ultra-miniature system employs complementary metal oxide semiconductor (CMOS) technology for its electronic components. The electronic components are either biocompatible or inert. The ASIC is attached to a circular microcoil antenna made of gold and both of these components are hermetically encapsulated in platinum-cured silicone. This biocompatible silicone material makes up the entire surface of the implant. The implant itself is designed to remain in-vivo indefinitely. The outside diameter of the transponder disc is only 11.3 mm, inside diameter is 7 mm, its thickness is 0.9 mm and the weight is 0.1 g.

“The device seems to be very well tolerated in the eye” said Melki, who implanted the device 18months ago at the Beirut Eye Specialist Hospital. “Although more studies need to be conducted, we have seen no side effects until now”.

There are several benefits to the novelmethod.It allows IOP measurements wirelessly through radiofrequency whichoffers the prospect of lifelong frequent eye pressure monitoring. It may reduce the number of doctors’ visits and provide measurements at times that were inaccessible previously such as during sleep. This may allow glaucoma specialists to understand why certain patients still lose vision despite seemingly low pressures. The device is not FDA-approved at this time.

For more information, contact Rick Young at Rick(at)bostoneyegroup(dot)com or Max Ostermeier at mostermeier(at)implandata(dot)com. You can also visit http://www.bostoneyegroup.com or call 617-566-0062.

Read the full story at http://www.prweb.com/releases/2013/1/prweb10354744.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Linguists to gather in Boston for National Conference
2. Northofbostonusa.com Will Release its N5 Fashion Shoes Next Monday
3. Boston College researcher looks to stop a deadly parasite in its tracks
4. Boston Medical Center awarded elite distinction as a 2012 Leapfrog Top Hospital
5. Cincinnati and Boston Childrens Hospitals receive an NIH Autism Center of Excellence Grant
6. Boston University researchers expand synthetic biologys toolkit
7. Snoring Isn’t Sexy Member, Dr. Mark Levy attends the American Academy of Dental Sleep Medicine Meeting in Boston, MA
8. SLEEP 2012 presents latest in sleep medicine and research June 11-13 in Boston
9. Boston researcher, surgical oncologist receives national award
10. Leaders in childrens health to gather in Boston
11. US Drug Watchdog Now Urges Users of Yaz Yasmin Birth Control Pills That Had a Stroke Or Developed Other Serious Medical Conditions to Contact The Johnson Law Group
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... ... March 24, 2017 , ... Empower Brokerage, located in Southlake, ... leads programs. , In February, 2017, Empower Brokerage introduced their new “Performance Partners” ... designed to teach how to maximize their sales efforts, as well as how ...
(Date:3/24/2017)... ... March 24, 2017 , ... “Vintage and Harvest A Cultivation of ... college Bible teacher residing in North Carolina with his wife, Anna Marie. He and ... with six grandchildren. David is also the author of “Shadow and Substance.” , “Love, ...
(Date:3/23/2017)... ... March 23, 2017 , ... A recent report from the National Council ... programs. The NCTQ report suggests, based on a review of GPA and SAT/ACT requirements ... quality in the U.S. It argues that this higher bar should be set by ...
(Date:3/23/2017)... ... March 23, 2017 , ... ... Center at 10 North Broadway Avenue, will be an educational and exciting program ... instruction in the management of chronic pain. , Oklahoma is in a healthcare ...
(Date:3/23/2017)... (PRWEB) , ... March 23, ... ... and financial services firm serving the families and businesses of the Norwalk ... enrichment program. Northern Ohio Recovery Center (N.O.R.A.) is a nonprofit, community-based substance ...
Breaking Medicine News(10 mins):
(Date:3/24/2017)... , Mar. 24, 2017 Research ... Management in the U.S.: Consumer Strategies" report to their ... ... how adults approach and treat their physical pain, emphasizing consumer ... distinct groups: pain sufferers and adults who have selected illnesses/conditions ...
(Date:3/24/2017)... SHANGHAI , March 24, 2017 /PRNewswire/ ... organization providing high-quality and cost-effective drug development ... the pharmaceutical and biotechnology industry, announced today ... ShangPharma will be consolidating the ... Organizations (CMO) under Shanghai ChemPartner. These entities ...
(Date:3/24/2017)... -- Research and Markets has announced the addition of the ... their offering. ... pipeline is very strong with a total of 97 drug candidates. Pharma ... Sanofi are involved in the development of the IPF therapeutics. The IPF ... III stage, 15 are in Phase II stage, 12 are in Phase ...
Breaking Medicine Technology: